Effectiveness of photodynamic therapy in the treatment of lichen sclerosus: cell changes in immunohistochemistry
- PMID: 20010496
Effectiveness of photodynamic therapy in the treatment of lichen sclerosus: cell changes in immunohistochemistry
Abstract
Background: Vulvar lichen sclerosus (LS) affects primarily women at postmenopausal age and its background remains unknown. One of the treatment modalities is photodynamic therapy (PDT). The aim was to investigate the efficacy of PDT in women with LS and the analysis of protein expression before and after PDT.
Material and methods: From 04.2006-01.2008 28 women, with LS underwent photodynamic diagnosis and next PDT: six-courses every second week with using 5-aminolevulinic acid (ALA) as a photosensitizer. Punch biopsies were taken before and after treatment and immunohistochemistry was done with Ki67,CD44,CD34 and CD3.
Results: Before PDT all patients suffered from pruritus and after in 89.3% the relief was noted. The histological examination showed that 35.7% patients hadn't LS after therapy completion. Anti-CD44 staining intensities was scored qualitatively - there were no statistical difference at the expression of protein CD44 in the epidermis (p>0.05) before and after therapy. Microvessel density was assessed at the hot spots, marked with anti-CD34. Statistical difference in AVD before and after therapy: (p<0.05). The staining intensity of Ki-67 didn't differ before and after PDT (p>0.05). The expression of CD3 on T lymphocytes showed statistical difference of the lymphocytic infiltration before and after PDT ( p<0.05).
Conclusion: The immunohistochemical staining in vulvar LS showed increasing microvessel density and decreasing lymphocytic infiltration. There were a clinical, and less histological improvement in patients with LS. We suggest that the photodynamic therapy is an effective, alternative treatment in some but not all patients with LS. Therefore, further studies are needed.
Similar articles
-
Topical 5-aminolevulinic acid (ALA)-photodynamic therapy (PDT) for lichen sclerosus of face: case report and literature review.Lasers Med Sci. 2024 Jan 31;39(1):53. doi: 10.1007/s10103-024-04004-3. Lasers Med Sci. 2024. PMID: 38291288 Review.
-
ALA-Photodynamic treatment in Lichen sclerosus-clinical and immunological outcome focusing on the assesment of antinuclear antibodies.Photodiagnosis Photodyn Ther. 2017 Jun;18:128-132. doi: 10.1016/j.pdpdt.2017.02.006. Epub 2017 Feb 17. Photodiagnosis Photodyn Ther. 2017. PMID: 28219801 Clinical Trial.
-
Response of vulval lichen sclerosus and squamous hyperplasia to photodynamic treatment using sustained topical delivery of aminolevulinic acid from a novel bioadhesive patch system.Photodermatol Photoimmunol Photomed. 2009 Apr;25(2):111-3. doi: 10.1111/j.1600-0781.2009.00410.x. Photodermatol Photoimmunol Photomed. 2009. PMID: 19292790 Clinical Trial.
-
Clinical and immunohistochemical evaluation of psoriatic plaques treated with topical 5-aminolaevulinic acid photodynamic therapy.Photodermatol Photoimmunol Photomed. 2005 Dec;21(6):326-32. doi: 10.1111/j.1600-0781.2005.00182.x. Photodermatol Photoimmunol Photomed. 2005. PMID: 16313245 Clinical Trial.
-
Non-oncologic indications for ALA-PDT.J Dermatolog Treat. 2002;13 Suppl 1:S13-8. doi: 10.1080/095466302317414654. J Dermatolog Treat. 2002. PMID: 12060512 Review.
Cited by
-
The Immunogenetic Aspects of Photodynamic Therapy.Adv Exp Med Biol. 2022;1367:433-448. doi: 10.1007/978-3-030-92616-8_18. Adv Exp Med Biol. 2022. PMID: 35286707
-
[Lichen sclerosus in the genitourinary region].Urologe A. 2011 Oct;50(10):1291-6. doi: 10.1007/s00120-011-2710-8. Urologe A. 2011. PMID: 21927875 Review. German.
-
The use of photodynamic therapy in medical practice.Front Oncol. 2024 May 8;14:1373263. doi: 10.3389/fonc.2024.1373263. eCollection 2024. Front Oncol. 2024. PMID: 38803535 Free PMC article. Review.
-
5-Aminolevulinic acid photodynamic therapy in refractory vulvar lichen sclerosus et atrophicus: Series of ten cases.Photodiagnosis Photodyn Ther. 2018 Mar;21:234-238. doi: 10.1016/j.pdpdt.2017.12.003. Epub 2017 Dec 16. Photodiagnosis Photodyn Ther. 2018. PMID: 29258952 Free PMC article.
-
Topical 5-aminolevulinic acid (ALA)-photodynamic therapy (PDT) for lichen sclerosus of face: case report and literature review.Lasers Med Sci. 2024 Jan 31;39(1):53. doi: 10.1007/s10103-024-04004-3. Lasers Med Sci. 2024. PMID: 38291288 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous